Employing PEG crosslinkers to optimize cell viability in gel phase bioinks and tailor post printing mechanical properties.


Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
11 2019
Historique:
received: 28 04 2019
revised: 26 08 2019
accepted: 07 09 2019
pubmed: 21 9 2019
medline: 21 10 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

The field of 3D bioprinting has rapidly grown, yet the fundamental ability to manipulate material properties has been challenging with current bioink methods. Here, we change bioink properties using our PEG cross-linking (PEGX) bioink method with the objective of optimizing cell viability while retaining control of mechanical properties of the final bioprinted construct. First, we investigate cytocompatible, covalent cross-linking chemistries for bioink synthesis (e.g. Thiol Michael type addition and bioorthogonal inverse electron demand Diels-Alder reaction). We demonstrate these reactions are compatible with the bioink method, which results in high cell viability. The PEGX method is then exploited to optimize extruded cell viability by manipulating bioink gel robustness, characterized by mass flow rate. Below a critical point, cell viability linearly decreases with decreasing flow rates, but above this point, high viability is achieved. This work underscores the importance of building a foundational understanding of the relationships between extrudable bioink properties and cell health post-printing to more efficiently tune material properties for a variety of tissue and organ engineering applications. Finally, we also develop a post-printing, cell-friendly cross-linking strategy utilizing the same reactions used for synthesis. This secondary cross-linking leads to a range of mechanical properties relevant to soft tissue engineering as well as highly viable cell-laden gels stable for over one month in culture. STATEMENT OF SIGNIFICANCE: We demonstrate that a PEG crosslinking bioink method can be used with various cytocompatible, covalent cross-linking reactions: Thiol Michael type addition and tetrazine-norbornene click. The ability to vary bioink chemistry expands candidate polymers, and therefore can expedite development of new bioinks from unique polymers. We confirm post-printed cell viability and are the first to probe, in covalently cross-linked inks, how cell viability is impacted by different flow properties (mass flow rate). Finally, we also present PEG cross-linking as a new method of post-printing cross-linking that improves mechanical properties and stability while maintaining cell viability. By varying the cross-linking reaction, this method can be applicable to many types of polymers/inks for easy adoption by others investigating bioinks and hydrogels.

Identifiants

pubmed: 31539655
pii: S1742-7061(19)30619-1
doi: 10.1016/j.actbio.2019.09.007
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Cross-Linking Reagents 0
Heterocyclic Compounds, 1-Ring 0
Hydrogels 0
Norbornanes 0
tetrazine dye 10 0
2-norbornene 2Q51FLS550
Polyethylene Glycols 3WJQ0SDW1A
Gelatin 9000-70-8

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-132

Informations de copyright

Published by Elsevier Ltd.

Auteurs

Alexandra L Rutz (AL)

Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA; Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA.

Emma S Gargus (ES)

Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA; Department of Obstetrics & Gynecology, Northwestern University, Chicago, IL 60611, USA.

Kelly E Hyland (KE)

Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA; Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA.

Phillip L Lewis (PL)

Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA; Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA.

Aakash Setty (A)

Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA.

Wesley R Burghardt (WR)

Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA; Department of Chemical and Biological Engineering, Northwestern University, Evanston, IL 60208, USA.

Ramille N Shah (RN)

Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, IL 60611, USA; Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA; Department of Materials Science and Engineering, Northwestern University, Evanston, IL 60208, USA; Department of Surgery - Organ Transplantation, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA; Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH